This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Synthetic data advancements bring new patent infringement risk

By Nick Robertson ( November 19, 2025, 22:10 GMT | Insight) -- The recent proliferation of synthetic data, especially in medical research, may increase patent infringement litigation risk for innovative companies via unintended disclosures of research methods and uses, attorneys tell MLex. A recent Western District of Texas complaint is raising concerns that many innovative companies may be overlooking the patent infringement risk brought by the rising use of synthetic data, attorneys tell MLex.  ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections